UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Incidence of and predictors for direct acting antiviral treatment failure among 3909 hepatitis C genotype 1 infected adults: real world outcomes from HCV TARGET

Journal of hepatology, 2017, Vol.66 (1), p.S719-S720

2017

Volltextzugriff (PDF)

Safety and efficacy of velpatasvir and sofosbuvir with or without ribavirin for the treatment of HCV genotypes 1–6: results of the HCV-TARGET Study

Journal of hepatology, 2017, Vol.66 (1), p.S716-S717

2017

Volltextzugriff (PDF)

P411 A SHORTER ESTIMATED DURATION OF INFECTION IN CHINA VERSUS US MAY ACCOUNT FOR THE LOWER PREVALENCE OF HCV-RELATED CIRRHOSIS AND HCC IN CHINA

Journal of hepatology, 2014-04, Vol.60 (1), p.S205-S205

2014

Volltextzugriff (PDF)

P1272 : A comparative study of patient satisfaction with liver disease care in the United States and Urban and rural China

Journal of hepatology, 2015-04, Vol.62, p.S835-S836

2015

Volltextzugriff (PDF)

P0646 : Lower risk of hepatocellular carcinoma in chronic hepatitis B patients treated with entecavir: A reach-B analysis of the enumerate study

Journal of hepatology, 2015-04, Vol.62, p.S562-S562

2015

Volltextzugriff (PDF)

1417 SUSTAINED VIROLOGIC RESPONSE WITH DACLATASVIR PLUS SOFOSBUVIR ± RIBAVIRIN (RBV) IN CHRONIC HCV GENOTYPE (GT) 1-INFECTED PATIENTS WHO PREVIOUSLY FAILED TELAPREVIR (TVR) OR BOCEPREVIR (BOC)

Journal of hepatology, 2013-04, Vol.58, p.S570-S570

2013

Volltextzugriff (PDF)

1336 IL28B GENETIC ATTRIBUTABLE RISK IN HEPATITIS C-ASSOCIATED HEPATOCELLULAR CARCINOMA AND DECOMPENSATED LIVER DISEASE

Journal of hepatology, 2011-03, Vol.54, p.S527-S528

2011

Volltextzugriff (PDF)

1339 IL28B GENETIC VARIANTS AND GENDER ARE ASSOCIATED WITH SPONTANEOUS CLEARANCE OF HEPATITIS C VIRUS INFECTION

Journal of hepatology, 2011-03, Vol.54, p.S529-S529

2011

Volltextzugriff (PDF)

355 WHICH PATIENTS WITH CHRONIC HEPATITIS B (CHB) ARE BIOPSIED?

Journal of hepatology, 2009, Vol.50, p.S136-S136

2009

Volltextzugriff (PDF)

Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection

Gastroenterology (New York, N.Y. 1943), 2016-02, Vol.150 (2), p.419-429

2016

Volltextzugriff (PDF)

101 INCIDENCE RATES AND RISK FACTORS ASSOCIATED WITH HEPATOCELLULAR CARCINOMA (HCC) IN PATIENTS WITH ADVANCED LIVER DISEASE DUE TO HEPATITIS C: RESULTS OF THE HALT-C TRIAL

Journal of hepatology, 2008, Vol.48, p.S45-S45

2008

Volltextzugriff (PDF)

Duodenal Permeability Is Associated With Mucosal Microbiota in Compensated Cirrhosis

Clinical and translational gastroenterology, 2022-10, Vol.13 (10), p.e00522-e00522

2022

Volltextzugriff (PDF)

SAT-229 - Incidence of and predictors for direct acting antiviral treatment failure among 3909 hepatitis C genotype 1 infected adults: real world outcomes from HCV TARGET

Journal of hepatology, 2017, Vol.66 (1), p.S719-S720

2017

Volltextzugriff (PDF)

SAT-222 - Safety and efficacy of velpatasvir and sofosbuvir with or without ribavirin for the treatment of HCV genotypes 1–6: results of the HCV-TARGET Study

Journal of hepatology, 2017, Vol.66 (1), p.S716-S717

2017

Volltextzugriff (PDF)

Phos-tag analysis of Rab10 phosphorylation by LRRK2: a powerful assay for assessing kinase function and inhibitors

Biochemical journal, 2016-09, Vol.473 (17), p.2671-2685

2016

Volltextzugriff (PDF)

Primary Endpoint Results of NRG CC003: Phase IIR/III Trial of Prophylactic Cranial Irradiation (PCI) with or without Hippocampal Avoidance (HA) for Small Cell Lung Cancer (SCLC)

International journal of radiation oncology, biology, physics, 2023-11, Vol.117 (4), p.e3-e3

2023

Volltextzugriff (PDF)

Design and rationale for a real-world observational cohort of patients with nonalcoholic fatty liver disease: The TARGET-NASH study

Contemporary clinical trials, 2017-10, Vol.61, p.33-38

2017

Volltextzugriff (PDF)

EP03.01-016 The Canadian Small Cell Lung Cancer Database (CASCADE): Results from a Multi-Institutional Real-World Evidence Collaboration

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S244

2022

Volltextzugriff (PDF)

EP14.05-020 Population-based Outcomes for Patients with Extensive-Stage Small-cell Lung Cancer from the Canadian SCLC Database (CASCADE)

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S552

2022

Volltextzugriff (PDF)

EP14.04-001 Treatment and Outcomes of Patients with Limited-Stage Small-cell Lung Cancer in the Canadian SCLC Database (CASCADE)

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S542

2022

Volltextzugriff (PDF)

Nonuraemic calciphylaxis: A case series

Annales de dermatologie et de vénéréologie, 2021-06, Vol.148 (2), p.127-129

2021

Volltextzugriff (PDF)

P0460 : CD3hiCD4- Vγ9/Vδ2 TCR+ gamma delta T cells with Th1 and NK-like phenotype are induced in patients with chronic hepatitis B

Journal of hepatology, 2015-04, Vol.62, p.S485-S485

2015

Volltextzugriff (PDF)

Perceived ethnic discrimination, suicidal ideation and mastery in a multi-ethnic cohort: the HELIUS study

BJPsych open, 2023-01, Vol.9 (1), p.e21-e21, Article e21

2023

Volltextzugriff (PDF)

P163 IMMUNE CORRELATES OF VACCINE-MEDIATED PROTECTIVE IMMUNITY VERSUS VIRAL PERSISTENCE IN HEPATITIS B VIRUS INFECTION

Journal of hepatology, 2014-04, Vol.60 (1), p.S120-S120

2014

Volltextzugriff (PDF)

Calciphylaxie chez des patients non insuffisants rénaux : série de 10 cas

Annales de dermatologie et de vénéréologie, 2018-12, Vol.145 (12), p.S300-S301

2018

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(27)
Tagungsberichte
(3)

Sprache

Englisch
(28)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

Gastroenterology And Hepatology
(13)
Science & Technology
(8)
Life Sciences & Biomedicine
(7)
Humans
(3)
Adult
(2)
Aged
(2)
Bandwidth
(2)
Block Codes
(2)
Channel Estimation
(2)
Female
(2)
Gastroenterology & Hepatology
(2)
Male
(2)
Middle Aged
(2)
Young Adult
(2)
Adaptation
(1)
Adaptation, Physiological - Genetics
(1)
Adolescent
(1)
Aged, 80 And Over
(1)
Amino Acids
(1)
Animals
(1)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Incidence of and predictors for direct acting antiviral treatment failure among 3909 hepatitis C genotype 1 infected adults: real world outcomes from HCV TARGET

Safety and efficacy of velpatasvir and sofosbuvir with or without ribavirin for the treatment of HCV genotypes 1–6: results of the HCV-TARGET Study

P411 A SHORTER ESTIMATED DURATION OF INFECTION IN CHINA VERSUS US MAY ACCOUNT FOR THE LOWER PREVALENCE OF HCV-RELATED CIRRHOSIS AND HCC IN CHINA

P1272 : A comparative study of patient satisfaction with liver disease care in the United States and Urban and rural China

P0646 : Lower risk of hepatocellular carcinoma in chronic hepatitis B patients treated with entecavir: A reach-B analysis of the enumerate study

1417 SUSTAINED VIROLOGIC RESPONSE WITH DACLATASVIR PLUS SOFOSBUVIR ± RIBAVIRIN (RBV) IN CHRONIC HCV GENOTYPE (GT) 1-INFECTED PATIENTS WHO PREVIOUSLY FAILED TELAPREVIR (TVR) OR BOCEPREVIR (BOC)

1336 IL28B GENETIC ATTRIBUTABLE RISK IN HEPATITIS C-ASSOCIATED HEPATOCELLULAR CARCINOMA AND DECOMPENSATED LIVER DISEASE

1339 IL28B GENETIC VARIANTS AND GENDER ARE ASSOCIATED WITH SPONTANEOUS CLEARANCE OF HEPATITIS C VIRUS INFECTION

355 WHICH PATIENTS WITH CHRONIC HEPATITIS B (CHB) ARE BIOPSIED?

Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection

101 INCIDENCE RATES AND RISK FACTORS ASSOCIATED WITH HEPATOCELLULAR CARCINOMA (HCC) IN PATIENTS WITH ADVANCED LIVER DISEASE DUE TO HEPATITIS C: RESULTS OF THE HALT-C TRIAL

Duodenal Permeability Is Associated With Mucosal Microbiota in Compensated Cirrhosis

SAT-229 - Incidence of and predictors for direct acting antiviral treatment failure among 3909 hepatitis C genotype 1 infected adults: real world outcomes from HCV TARGET

SAT-222 - Safety and efficacy of velpatasvir and sofosbuvir with or without ribavirin for the treatment of HCV genotypes 1–6: results of the HCV-TARGET Study

Phos-tag analysis of Rab10 phosphorylation by LRRK2: a powerful assay for assessing kinase function and inhibitors

Primary Endpoint Results of NRG CC003: Phase IIR/III Trial of Prophylactic Cranial Irradiation (PCI) with or without Hippocampal Avoidance (HA) for Small Cell Lung Cancer (SCLC)

Design and rationale for a real-world observational cohort of patients with nonalcoholic fatty liver disease: The TARGET-NASH study

EP03.01-016 The Canadian Small Cell Lung Cancer Database (CASCADE): Results from a Multi-Institutional Real-World Evidence Collaboration

EP14.05-020 Population-based Outcomes for Patients with Extensive-Stage Small-cell Lung Cancer from the Canadian SCLC Database (CASCADE)

EP14.04-001 Treatment and Outcomes of Patients with Limited-Stage Small-cell Lung Cancer in the Canadian SCLC Database (CASCADE)

Nonuraemic calciphylaxis: A case series

P0460 : CD3hiCD4- Vγ9/Vδ2 TCR+ gamma delta T cells with Th1 and NK-like phenotype are induced in patients with chronic hepatitis B

Perceived ethnic discrimination, suicidal ideation and mastery in a multi-ethnic cohort: the HELIUS study

P163 IMMUNE CORRELATES OF VACCINE-MEDIATED PROTECTIVE IMMUNITY VERSUS VIRAL PERSISTENCE IN HEPATITIS B VIRUS INFECTION

Calciphylaxie chez des patients non insuffisants rénaux : série de 10 cas

Suchergebnisse filtern